top of page


NFL Biosciences successful IPO on Euronext Growth Paris
June 30, 2021

NFL Biosciences launches IPO on Euronext Growth Paris
June 16, 2021

A French innovation for smoking cessation approved for a Phase II clinical study
June 2, 2021


  • A novel botanical approach to smoking cessation to be tested on 318 smokers

  • A Phase II clinical trial approved by the Human Research Ethics Committee (HREC) in Australia to avoid the effects of the health crisis in Europe

bottom of page